Widespread carboplatin, cisplatin shortages: NCCN surveyJune 9, 2023Patient & Survivor CarePractice ManagementLung CancerBreast CancerGenitourinary CancerNonmelanoma Skin CancerMetastatic Breast Cancer
ER+/HER2– breast cancer: Is first or second line CDK4/6 inhibitor therapy better?June 7, 2023Breast CancerPatient & Survivor Care
Ribociclib forestalls recurrence also in early breast cancerJune 4, 2023Breast CancerMetastatic Breast CancerPatient & Survivor Care
Phone support helps weight loss in patients with breast cancerJune 4, 2023Breast CancerPreventive CarePatient & Survivor Care
Chemo avoidance pays off for some women with HER2+ early BCJune 4, 2023Breast CancerPatient & Survivor Care
Breast cancer: Meta-analysis supports ovarian suppression/ablationJune 4, 2023Breast CancerPreventive CarePatient & Survivor Care
How a medical recoding may limit cancer patients’ options for breast reconstructionJune 1, 2023Practice ManagementBreast CancerPatient & Survivor Care
Lack of paid sick leave is a barrier to cancer screeningMay 30, 2023Breast CancerGastrointestinal CancerPreventive Care
Circulating tumor DNA may predict poor prognosis in breast cancerMay 24, 2023Breast CancerPatient & Survivor Care
Breast cancer outcomes are worse for Black menMay 24, 2023Breast CancerPatient & Survivor CarePractice ManagementPreventive CareDiversity in Medicine
Breast cancer survivors need a comprehensive care plan, says doctorMay 19, 2023Breast CancerPatient & Survivor CarePractice Management
Atezolizumab is associated with enhanced response in triple-negative breast cancerMay 16, 2023Breast Cancer
